64 related articles for article (PubMed ID: 7302939)
1. [Salbutamol in children with CARA; a comparison of administration with tablets and with the Rotahaler].
van der Ploeg RJ; Tolhoek HJ; Akkerboom JC; Knol K
Tijdschr Kindergeneeskd; 1981 Jun; 49(3):92-9. PubMed ID: 7302939
[No Abstract] [Full Text] [Related]
2. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
Brändli O; Langloh P
Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
[No Abstract] [Full Text] [Related]
3. [Treatment of spastic disorders of the bronchopulmonary tract with salbutamol tablets].
Kandus J
Vnitr Lek; 1979 Aug; 25(8):797-803. PubMed ID: 506082
[No Abstract] [Full Text] [Related]
4. Inhaled powder and aerosol salbutamol in metacholine-induced bronchial obstruction.
Lahdensuo A; Sovijärvi A; Muittari A
Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():515-7. PubMed ID: 6352312
[No Abstract] [Full Text] [Related]
5. Experiences with large doses of beta 2-agonists inhaled from nebulizers.
Larsson S
Postgrad Med J; 1983; 59 Suppl 3():71-2. PubMed ID: 6647211
[TBL] [Abstract][Full Text] [Related]
6. [Effect of salbutamol in patients with chronic obstructive lung disease (author's transl)].
Pasquis P; Nouvet G; Denis P; David P; Lefrançois R; Morère P
Therapie; 1981; 36(1):81-5. PubMed ID: 7233376
[No Abstract] [Full Text] [Related]
7. [Salbutamol in the treatment of functional broncho-obstructive syndromes].
Fiora L
Minerva Med; 1976 Apr; 67(17):1165-75. PubMed ID: 1264395
[No Abstract] [Full Text] [Related]
8. Comparative evaluation of lung functional changes with atropine methonitrate and salbutamol in plain and sustained forms.
Patel MH; Kolhatkar VP; Mahashur AA; Kamat SR
J Assoc Physicians India; 1986 Oct; 34(10):717-8. PubMed ID: 3818522
[No Abstract] [Full Text] [Related]
9. A new, modified form of inhaler ('Rotahaler') for patients with chronic obstructive lung disease.
Pover GM; Dash CH
Pharmatherapeutica; 1985; 4(2):98-101. PubMed ID: 3903783
[TBL] [Abstract][Full Text] [Related]
10. The place for albuterol aerosol in chronic obstructive airway disease: maximizing its use.
Middleton E
Ann Allergy; 1981 Nov; 47(5 Pt 2):427-8. PubMed ID: 6795977
[No Abstract] [Full Text] [Related]
11. [Bronchodilator capacity of salbutamol aerosol after its long-term use].
Szmidt M; Kosiński SW; Rózniecki J
Pol Arch Med Wewn; 1983; 70(5-6):251-8. PubMed ID: 6677889
[No Abstract] [Full Text] [Related]
12. [The use of oral water-alcohol solutions of theophylline and salbutamol in the elderly: evaluation of blood theophylline after single and multiple doses].
Guggino G; Ricca Rosellini S; Ronchi A
G Clin Med; 1983; 64(5-6):209-15. PubMed ID: 6618056
[No Abstract] [Full Text] [Related]
13. Effect of salbutamol on oxygen saturation in COPD.
Charoenratanakul S; Borrirukwanit K
J Med Assoc Thai; 1996 Apr; 79(4):218-21. PubMed ID: 8708506
[TBL] [Abstract][Full Text] [Related]
14. Salbutamol inhalation: rotahaler v. pressurised aerosol.
Drug Ther Bull; 1978 Jul; 16(15):59-60. PubMed ID: 688860
[No Abstract] [Full Text] [Related]
15. [Broncholytic activity of dose-adjusted aerosols in active respiratory tuberculosis].
Vizel' AA; Iaushev MF; Mustafin RR; Goncharova LV
Probl Tuberk; 1995; (2):7-9. PubMed ID: 7777469
[No Abstract] [Full Text] [Related]
16. [Ambulatory care of obstructive ventilation disorders with salbutamol].
Hofmann AC
Fortschr Med; 1972 May; 90(14):559-61. PubMed ID: 5072278
[No Abstract] [Full Text] [Related]
17. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
[TBL] [Abstract][Full Text] [Related]
18. [Response to inhaled bronchodilators in chronic airway obstruction].
Holten K
Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
[TBL] [Abstract][Full Text] [Related]
19. Salbutamol psychosis.
Whitehouse AM; Novosel S
Biol Psychiatry; 1989 Oct; 26(6):631-3. PubMed ID: 2790100
[No Abstract] [Full Text] [Related]
20. Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma.
Kunkel G; Chuchalin AG
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S15-7. PubMed ID: 11385811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
